AWM Investment Company’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

AWM Investment Company’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-200,000	Closed	-$1.74M	–	97
2018 Q2	$1.74M	Buy	200,000 +50,000	+33%	+$450K	0.29%	70
2018 Q1	$1.52M	Buy	+150,000	New	+$1.26M	0.29%	70
2017 Q3	–	Sell	-100,000	Closed	-$505K	–	100
2017 Q2	$505K	Hold	100,000	–	–	0.09%	82
2017 Q1	$475K	Buy	+100,000	New	+$505K	0.09%	87

AWM Investment Company's JNP Position: Q3 2018 in Review

AWM Investment Company sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 200,000 shares — an estimated $1.74M sold.

AWM Investment Company first reported a position in JNP in Q1 2017 and held it in 4 quarters. The position peaked at $1.74M in Q2 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

AWM Investment Company reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
AWM Investment Company sold 200,000 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $1.74M.
AWM Investment Company first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q1 2017 and held it in 4 quarters.
AWM Investment Company's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $1.74M in Q2 2018.
0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on AWM Investment Company's 13F filing for Q3 2018, filed 9 Nov 2018.